# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam a...
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stoc...
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses...